CON vs. MEDP: Which Stock Is the Better Value Option?

Core Viewpoint - The comparison between Concentra Group (CON) and Medpace (MEDP) indicates that CON presents a better value opportunity for investors at this time [1]. Group 1: Zacks Rank and Earnings Outlook - CON has a Zacks Rank of 2 (Buy), while MEDP has a Zacks Rank of 3 (Hold), suggesting that CON is likely experiencing a more favorable earnings outlook [3]. - The Zacks Rank focuses on companies with positive earnings estimate revisions, which is a key factor for value investors [2]. Group 2: Valuation Metrics - CON has a forward P/E ratio of 17.37, compared to MEDP's forward P/E of 26.73, indicating that CON may be undervalued relative to MEDP [5]. - The PEG ratio for CON is 2.08, while MEDP's PEG ratio is 3.63, further suggesting that CON has a more attractive valuation based on expected earnings growth [5]. - CON's P/B ratio is 10.37, whereas MEDP's P/B ratio is 12.37, reinforcing the notion that CON is more favorably valued [6]. Group 3: Value Grades - CON has a Value grade of B, while MEDP has a Value grade of C, indicating that CON is perceived as a better value investment [6].